Mariner’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Buy
212,539
+117,163
+123% +$1.26M ﹤0.01% 1243
2026
Q1
$807K Buy
95,376
+46,397
+95% +$508K ﹤0.01% 2120
2025
Q4
$555K Buy
48,979
+37,253
+318% +$462K ﹤0.01% 2374
2025
Q3
$176K Buy
11,726
+927
+9% +$13.5K ﹤0.01% 3219
2025
Q2
$152K Sell
10,799
-271
-2% -$4.83K ﹤0.01% 3137
2025
Q1
$266K Buy
11,070
+3,921
+55% +$138K ﹤0.01% 2740
2024
Q4
$267K Buy
7,149
+96
+1% +$4.48K ﹤0.01% 2732
2024
Q3
$353K Buy
+7,053
New +$274K ﹤0.01% 2430

Other funds holding BHVN

Mariner's BHVN Position: Q2 2026 in Review

Mariner increased its Biohaven (BHVN) stake by 123% in Q2 2026, buying an estimated $1.26M and bringing the position to 212,539 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Mariner first reported a position in BHVN in Q3 2024 and has held it in 8 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Mariner held 212,539 shares of Biohaven worth $3.16M as of Q2 2026.
  • Mariner bought 117,163 Biohaven shares in Q2 2026, an estimated $1.26M.
  • Biohaven made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1243 holding.
  • Mariner first reported a position in Biohaven in Q3 2024 and has held it in 8 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.